XACT Robotics announces $36M financing round

XACT Robotics, a radiology technology company with offices in the United States and Israel, raised $36 million in its latest financing round.

The funds are expected to go toward commercializing the company’s FDA-cleared hands-free robotic system, which allows users to plan and navigate various instruments through the use of medical imaging.

“As we continue to build momentum for our robotic system, we will use the recent funding to launch the system to select U.S. radiology Centers of Excellence partners,” Chen Levin, CEO of XACT Robotics, said in a prepared statement. “In addition, we will invest to continue expanding the utilization of the system and support our future launch cycle, including compatibility of the XACT Robotic System with additional imaging modalities and clinical applications to address a broad range of patient care needs.”

Chasing Value Asset Management, Mazor Robotics and Corindus Vascular Robotics all contributed to the financing round, joining existing shareholders such as Shizim Group and MEDX Ventures Group.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”